Page last updated: 2024-08-26

farrerol and Neointima

farrerol has been researched along with Neointima in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ge, R; Li, J; Li, Q; Liang, T; Liu, E; Shi, S1

Other Studies

1 other study(ies) available for farrerol and Neointima

ArticleYear
Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1/2 and p38 mitogen-activated protein kinase signaling.
    Molecular and cellular biochemistry, 2020, Volume: 475, Issue:1-2

    Topics: Animals; Aorta; Cells, Cultured; Chromones; Disease Models, Animal; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Contraction; Muscle, Smooth, Vascular; Neointima; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phytochemicals; Rats; Rats, Sprague-Dawley; Signal Transduction; Vascular System Injuries

2020